Evidence map›Paper›PMID 37658994›Full record

ArticleAnnals of intensive care2023

Characteristics and outcomes of patients with acute myeloid leukemia admitted to intensive care unit with acute respiratory failure: a post-hoc analysis of a prospective multicenter study.

Carolina Secreto, Dara Chean, Andry van de Louw, Achille Kouatchet, Philippe Bauer, Marco Cerrano, Etienne Lengliné, Colombe Saillard, Laurent Chow-Chine, Anders Perner and 12 more

Open access · goldAbstract read
In one paragraph

Article in Annals of intensive care, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 15 institutions in 10 countries.

Carolina SecretoDivision of Haematology, Department of Oncology, A.O.U. Città Della Salute e della Scienza di Torino, Turin, Italy. carolina.secreto@gmail.com.ORCID http://orcid.org/0000-0001-9624-615X
Dara CheanMédecine Intensive et Réanimation, APHP, Hôpital Saint Louis, Paris Cité University, Paris, France.
Andry van de LouwDivision of Pulmonary and Critical Care, Penn State University College of Medicine, Hershey, PA, USA.
Achille KouatchetDepartment of Medical Intensive Care Medicine, University Hospital of Angers, Angers, France.
Philippe BauerPulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA.
Marco CerranoDivision of Haematology, Department of Oncology, A.O.U. Città Della Salute e della Scienza di Torino, Turin, Italy.
Etienne LenglinéHématologie Adulte, Hôpital Saint-Louis, Université Paris Diderot, Paris, France.
Colombe SaillardHematology Department, Institut Paoli-Calmettes, Marseille, France.
Laurent Chow-ChineRéanimation Polyvalente et Département d'Anesthésie et de Réanimation, Institut Paoli-Calmettes, Marseille, France.
Anders PernerDepartment of Intensive Care, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Peter PickkersDepartment of Intensive Care Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
Marcio SoaresDepartment of Critical Care and Graduate Program in Translational Medicine, D'Or Institute for Research and Education, Programa de Pós-Graduação Em Clínica Médica, Rio De Janeiro, Brazil.
Jordi RelloVall d'Hebron Institute of Research, Barcelona, Spain.
Frédéric PèneMedical ICU, Cochin Hospital, Assistance Publique-Hôpitaux de Paris and University Paris Descartes, Paris, France.
Virginie LemialeMedical Intensive Care Unit, APHP, Hôpital Saint-Louis and Paris Diderot Sorbonne University, Paris, France.
Michael DarmonMedical Intensive Care Unit, APHP, Hôpital Saint-Louis and Paris Diderot Sorbonne University, Paris, France.
Sofiane FodilMedical Intensive Care Unit, APHP, Hôpital Saint-Louis and Paris Diderot Sorbonne University, Paris, France.
Ignacio Martin-LoechesDepartment of Intensive Care Medicine, St. James's Hospital, Dublin, Ireland.
Sangeeta MehtaSinai Health System and University of Toronto, Toronto, ON, Canada.
Peter SchellongowskiDepartment of Medicine I, Medical University of Vienna, Vienna, Austria.
Elie AzoulayMedical Intensive Care Unit, APHP, Hôpital Saint-Louis and Paris Diderot Sorbonne University, Paris, France.
Djamel MokartRéanimation Polyvalente et Département d'Anesthésie et de Réanimation, Institut Paoli-Calmettes, Marseille, France.
Délégation Paris 7 · FRInstitut Paoli-Calmettes · FRAzienda Ospedaliera Citta' della Salute e della Scienza di Torino · ITUniversité Paris Cité · FRDélégation Paris 5 · FRD’Or Institute for Research and Education · BRMayo Clinic in Florida · USMedical University of Vienna · ATPenn State Milton S. Hershey Medical Center · USRadboud University Nijmegen · NLSt. James's Hospital · IEUniversité d'Angers · FRUniversity of Copenhagen · DKUniversity of Toronto · CAVall d'Hebron Institut de Recerca · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAcute respiratory failure (ARF) is the leading cause of intensive care unit (ICU) admission in patients with Acute Myeloid Leukemia (AML) and data on prognostic factors affecting short-term outcome are needed.

methodsThis is a post-hoc analysis of a multicenter, international prospective cohort study on immunocompromised patients with ARF admitted to ICU. We evaluated hospital mortality and associated risk factors in patients with AML and ARF; secondly, we aimed to define specific subgroups within our study population through a cluster analysis.

resultsOverall, 201 of 1611 immunocompromised patients with ARF had AML and were included in the analysis. Hospital mortality was 46.8%. Variables independently associated with mortality were ECOG performance status ≥ 2 (OR = 2.79, p = 0.04), cough (OR = 2.94, p = 0.034), use of vasopressors (OR = 2.79, p = 0.044), leukemia-specific pulmonary involvement [namely leukostasis, pulmonary infiltration by blasts or acute lysis pneumopathy (OR = 4.76, p = 0.011)] and liver SOFA score (OR = 1.85, p = 0.014). Focal alveolar chest X-ray pattern was associated with survival (OR = 0.13, p = 0.001). We identified 3 clusters, that we named on the basis of the most frequently clinical, biological and radiological features found in each cluster: a "leukemic cluster", with high-risk AML patients with isolated, milder ARF; a "pulmonary cluster", consisting of symptomatic, highly oxygen-requiring, severe ARF with diffuse radiological findings in heavily immunocompromised patients; a clinical "inflammatory cluster", including patients with multi-organ failures in addition to ARF. When included in the multivariate analysis, cluster 2 and 3 were independently associated with hospital mortality.

conclusionsAmong AML patients with ARF, factors associated with a worse outcome are related to patient's background (performance status, leukemic pulmonary involvement), symptoms, radiological findings, the need for vasopressors and the liver SOFA score. We identified three specific ARF syndromes in AML patients, which showed a prognostic significance and could guide clinicians to optimize management strategies.

Indexed as

Acute myeloid leukemiaAcute respiratory failureCluster analysisHospital mortalityIntensive care unit

Identifiers

PMID37658994
PMCPMC10474995
OpenAlexW4386390728

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.